NEW YORK, March 06, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
DBV Technologies S.A. (DBVT)
Class Period: February 14, 2018 to December 19, 2018
Lead Plaintiff Deadline: March 18, 2019
The lawsuit alleges DBV Technologies S.A. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) DBV Technologies' Biologics License Application ("BLA") for Viaskin Peanut failed to provide the FDA with sufficient data on manufacturing procedures and quality controls; (2) consequently, DBV Technologies voluntarily withdrew the BLA for Viaskin Peanut; and (3) as a result, defendants' statements about DBV Technologies' business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis at all relevant times.
Get additional information about the DBVT lawsuit: http://www.kleinstocklaw.com/pslra-1/dbv-technologies-s-a-loss-submission-form?wire=3
Markel Corporation (MKL)
Class Period: July 26, 2017 to December 6, 2018
Lead Plaintiff Deadline: March 12, 2019
According to the complaint, Markel Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s subsidiaries did not appropriately record loss reserves; (2) as a result, the loss reserves would need to be adjusted and/or restated; (3) these misleading accounting practices would lead to regulatory scrutiny and financial loss to investors; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Get additional information about the MKL lawsuit: http://www.kleinstocklaw.com/pslra-1/markel-corporation-loss-submission-form?wire=3
Astec Industries, Inc. (ASTE)
Class Period: July 26, 2016 to October 22, 2018
Lead Plaintiff Deadline: April 2, 2019
The complaint alleges that throughout the Class Period, defendants made false and misleading statements and/or failed to disclose adverse information regarding Astec’s business, operations and prospects, including that its wood pellet plants suffered from significant and costly problems that prevented them from running at their promised production capacity, posing a threat to the Company’s pellet plant business, its overall financial performance, and its financial outlook. As a result of this information being withheld from the market, the price of Astec stock was artificially inflated to a high of nearly $70 per share during the Class Period.
Get additional information about the ASTE lawsuit: http://www.kleinstocklaw.com/pslra-1/astec-industries-inc-loss-submission-form?wire=3
Avon Products, Inc. (AVP)
Class Period: August 2, 2016 to August 2, 2017
Lead Plaintiff Deadline: April 15, 2019
In order to inflate its reported revenue and representative growth metric during the Class Period, Avon engaged in an undisclosed scheme whereby it significantly loosened its credit terms in order to recruit new representatives in Brazil, its largest market. Avon did not disclose the changes to its credit terms in Brazil. Avon also failed to increase its allowance for doubtful accounts to account for the changes to its credit terms in Brazil.
Get additional information about the AVP lawsuit: http://www.kleinstocklaw.com/pslra-1/avon-products-inc-loss-submission-form?wire=3
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.